López Hidalgo, Javier Luis
609  results:
Search for persons X
?
5

Defining the first bona fide cell model for SMARCA4-deficie..:

Arenas Molina, Alberto Manuel ; López Hidalgo, Javier Luis ; Medina Vico, Pedro Pablo
Arenas, A. M., Ruiz‐Jiménez, J. M., López‐Hidalgo, J. L., Sanjuán‐Hidalgo, J., & Medina, P. P. (2023). Defining the first bona fide cell model for SMARCA4‐deficient, undifferentiated tumor. The Journal of Pathology.[DOI:10.1002/path.6141].  , 2023
 
?
9

Generation of a H9 Clonal Cell Line With Inducible Expressi..:

Domingo Reinés, Joan ; Martínez Navajas, Gonzalo ; Montes, Rosa...
Domingo-Reinés J. [et al.] (2022) Generation of a H9 Clonal Cell Line With Inducible Expression of NUP98- KDM5A Fusion Gene in the AAVS1 Safe Harbor Locus. Front. Cell Dev. Biol. 10:846092. doi: [10.3389/fcell.2022.846092].  , 2022
 
?
12

Risk factors for ≥high-grade anal intraepithelial lesions i..:

Hidalgo Tenorio, Carmen ; García Martínez, Carmen María ; Pasquau Liaño, Juan..
Hidalgo-Tenorio C, García-Martínez CM, Pasquau J, Omar-Mohamed-Balgahata M, López-Ruz M, et al. (2021) Risk factors for ≥high-grade anal intraepithelial lesions in MSM living with HIV and the response to topical and surgical treatments. PLOS ONE 16(2): e0245870.0 [https://doi.org/10.1371/journal.pone.0245870].  , 2021
 
?
15

Uncovering Tumour Heterogeneity through PKR and nc886 Analy..:

Ortega García, María Belén ; Mesa, Alberto ; Moya, Elisa L. J...
Ortega-García, M. B., Mesa, A., Moya, E. L., Rueda, B., Lopez-Ordoño, G., García, J. Á., . & Peran, M. (2020). Uncovering tumour heterogeneity through PKR and nc886 analysis in metastatic colon cancer patients treated with 5-FU-based chemotherapy. Cancers, 12(2), 379..  , 2020
 
1-15